These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 2134622)
1. Alloimmunization as a problem for platelet transfusion. Bonacossa IA Transfus Med Rev; 1990 Apr; 4(2):144-8. PubMed ID: 2134622 [No Abstract] [Full Text] [Related]
2. The challenge of platelet alloimmunization: management and prevention. Kickler TS Transfus Med Rev; 1990 Oct; 4(4 Suppl 1):8-18. PubMed ID: 2134640 [TBL] [Abstract][Full Text] [Related]
3. Use of single donor platelets. Kirkley SA; Blumberg N Blood Rev; 1994 Sep; 8(3):142-7. PubMed ID: 7819816 [TBL] [Abstract][Full Text] [Related]
4. Platelet alloimmunization after transfusion. A prospective study in 117 heart surgery patients. Taaning E; Simonsen AC; Hjelms E; Svejgaard A; Morling N Vox Sang; 1997; 72(4):238-41. PubMed ID: 9228715 [TBL] [Abstract][Full Text] [Related]
5. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness. Brouk H; Bertrand G; Zitouni S; Djenouni A; Martageix C; Griffi F; Kaplan C; Ouelaa H Transfus Apher Sci; 2015 Jun; 52(3):295-9. PubMed ID: 25620758 [TBL] [Abstract][Full Text] [Related]
6. The role of UV radiation in the prevention of human leukocyte antigen alloimmunization. Andreu G; Boccaccio C; Klaren J; Lecrubier C; Pirenne F; Garcia I; Baudard M; Devers L; Fournel JJ Transfus Med Rev; 1992 Jul; 6(3):212-24. PubMed ID: 1498466 [No Abstract] [Full Text] [Related]
7. Alloantibodies and platelet destruction. Klein CA; Blajchman MA Semin Thromb Hemost; 1982 Apr; 8(2):105-15. PubMed ID: 7043738 [No Abstract] [Full Text] [Related]
9. Use of HLA- and HPA--matched platelets in alloimmunized patients. Kekomäki R Vox Sang; 1998; 74 Suppl 2():359-63. PubMed ID: 9704468 [TBL] [Abstract][Full Text] [Related]
10. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness]. Basire A; Picard C Transfus Clin Biol; 2014 Nov; 21(4-5):193-206. PubMed ID: 25277423 [TBL] [Abstract][Full Text] [Related]
12. The treatment of blood components with ultraviolet-B irradiation. Pamphilon DH Vox Sang; 1998; 74 Suppl 2():15-9. PubMed ID: 9704422 [No Abstract] [Full Text] [Related]
13. ABO and platelet transfusion therapy. Cooling L Immunohematology; 2007; 23(1):20-33. PubMed ID: 17425412 [No Abstract] [Full Text] [Related]
14. Review and update of platelet alloantigen systems. Mueller-Eckhardt C; Kiefel V; Santoso S Transfus Med Rev; 1990 Apr; 4(2):98-109. PubMed ID: 2134627 [No Abstract] [Full Text] [Related]
15. Identifying human leukocyte antigen (HLA)-compatible platelets using the Matchmaker programme in alloimmunised platelet-refractory patients. Kreuter JD Transfus Med; 2020 Feb; 30(1):5-6. PubMed ID: 32187786 [No Abstract] [Full Text] [Related]
16. [Prevention of HLA-alloimmunization of recipients of platelet concentrates]. Kuntz BM; Wollenhaupt HJ; Brüster HT Beitr Infusionsther; 1991; 28():209-12. PubMed ID: 1725621 [TBL] [Abstract][Full Text] [Related]
17. Detection of platelet-reactive antibodies in patients who are refractory to platelet transfusions, and the selection of compatible donors. Vox Sang; 2003 Jan; 84(1):73-88. PubMed ID: 12542737 [No Abstract] [Full Text] [Related]
19. Meta-analysis of randomized controlled trials of the efficacy of white cell reduction in preventing HLA-alloimmunization and refractoriness to random-donor platelet transfusions. Vamvakas EC Transfus Med Rev; 1998 Oct; 12(4):258-70. PubMed ID: 9798269 [No Abstract] [Full Text] [Related]
20. [Platelet transfusion refractoriness and effective management of platelet alloimmunization]. Amemiya Y Nihon Rinsho; 1997 Sep; 55(9):2392-8. PubMed ID: 9301306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]